Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04849364 |
|---|---|
| Brief Title: | Circulating Tumor DNA Enriched, Genomically Directed Post-neoadjuvant Trial for Patients With Residual Triple Negative Breast Cancer (PERSEVERE) |
| First Submitted : | April 13, 2021 |
| First Submitted that Met QC Criteria : | April 13, 2021 |
| First Posted : | April 19, 2021 |
| Last Update Submitted that Met QC Criteria : | November 9, 2023 |
| Last Update Posted : | November 13, 2023 |